Patents by Inventor Sandeep Gulati

Sandeep Gulati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9766126
    Abstract: An analyzer apparatus and method of use thereof is described to dynamically irradiate a sample with incident light where the incident light is varied in time in terms of any of: position, radial position relative to a point of the skin of a subject, solid angle, incident angle, depth of focus, energy, and/or intensity. For example, the incident light is varied in radial position as a function of time relative to one or more of a sample site, a point on skin of the subject, a detection optic, and/or a sample volume observed by a detection system. The radially varied incident light is used to enhance and/or vary light probing the epidermis, the dermis, and/or the subcutaneous fat of the subject or of a group of subjects.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: September 19, 2017
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Thomas George, Timothy L. Ruchti, Alan Abul-Haj, Kevin H. Hazen
  • Publication number: 20170156646
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Application
    Filed: August 17, 2016
    Publication date: June 8, 2017
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9610018
    Abstract: In a noninvasive system for measurement of heart rate and other heart-related characteristics a photoplethysmogram (PPG) obtained from a tissue is divided into several feature waveforms, each corresponding to a PPG window of a particular length. Conditioned features, containing frequency components specific to heart-related events, are derived from the features by modulating a carrier kernel with such features. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. For each conditioned feature, one or more collisions selectively amplify frequency components in features sourced from PPG, and respective energy change values are obtained from such amplified energy portions. The resulting energy change values are analyzed to determine a smallest time-window likely containing heart rate and other heart-related events in the PPG data stream.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: April 4, 2017
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, John L. Smith
  • Publication number: 20170035308
    Abstract: In a noninvasive system for measurement of heart rate and other heart-related characteristics a photoplethysmogram (PPG) obtained from a tissue is divided into several feature waveforms, each corresponding to a PPG window of a particular length. Conditioned features, containing frequency components specific to heart-related events, are derived from the features by modulating a carrier kernel with such features. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. For each conditioned feature, one or more collisions selectively amplify frequency components in features sourced from PPG, and respective energy change values are obtained from such amplified energy portions. The resulting energy change values are analyzed to determine a smallest time-window likely containing heart rate and other heart-related events in the PPG data stream.
    Type: Application
    Filed: August 10, 2016
    Publication date: February 9, 2017
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9554738
    Abstract: In a noninvasive system for detection/measurement of analytes in tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to the analytes, are derived from one or more features after modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify the energy absorbed by the analyte from radiation directed to the tissue. The value of the amplified energy is transformed into an accurate estimate of the concentration of the analyte. Depending on the analyte type, a particular tissue region is targeted and/or one or more parameters of the computational collision are selected.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: January 31, 2017
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, John L. Smith, William Van Antwerp
  • Patent number: 9459203
    Abstract: A synthetic projection system determines analyte concentration, such as blood glucose concentration, from a spectral-energy change associated with an uncharacterized instance of a medium in which the analyte is likely present. The projection system is factory calibrated for different instances of the medium, without needing instance-specific training or calibration. The projection system includes a set of projector curves, each relating spectral-energy change values obtained by analyzing reference medium samples to analyte concentrations in those samples. Each projector curve also corresponds to a respective range of energy-change gradients, determined using a group of surrogate media characterized according to analyte concentrations measured using a reference system. A spectral-energy-change gradient for the uncharacterized medium may be computed to select one of the projectors curves.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: October 4, 2016
    Assignee: Zyomed, Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9459201
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: October 4, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William V. Antwerp, John L. Smith
  • Patent number: 9459202
    Abstract: A collision-computing system detects and amplifies the energy associated with a feature signal to determine occurrences or absence of events, such as ultrasonic and/or geophysical events, or to determine presence and/or concentrations of substances such as blood glucose, toxic chemicals, etc., in a noisy, high-clutter environment or sample. To this end, a conditioned feature, obtained by modulating a carrier kernel with a feature signal, is collided with a Zyoton—a waveform that without a collision can travel substantially unperturbed in a propagation medium over a specified distance. The conditioned feature and the Zyoton are particularly constructed to be co-dependent in terms of their respective dispersion velocities and the divergence of a waveform resulting from the collision. The collision operation can transfer at least a portion of the feature energy to the resulting waveform, and the transferred energy can be amplified in successive collisions for detecting/measuring events/substances.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: October 4, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9453794
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, illumination is directed to the medium and corresponding radiation from the medium is collected. Spectral energy changes associated with fragment(s)/feature(s) obtained from the collected radiation are determined using collision computing. Such spectral energy changes generally represent analyte concentration. The illumination is controlled to target a particular volume of the medium and/or such that the spectral energy changes become directionally monotonic with respect to analyte concentration.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: September 27, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9448164
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: September 20, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Patent number: 9448165
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, illumination is directed to the medium and corresponding radiation from the medium is collected. Spectral energy changes associated with fragment(s)/feature(s) obtained from the collected radiation are determined using collision computing. Such spectral energy changes generally represent analyte concentration. The collection of radiation and/or illumination is controlled either to target a particular volume of the medium or such that the spectral energy changes become directionally monotonic with respect to analyte concentration, or both. The collection parameters include: duration of collection, location and/or a size of a collection spot on the medium surface, and angle of a collector relative to the medium surface. The illuminated and/or collection spots may be treated to improve accuracy of analyte measurement.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: September 20, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti, John L. Smith, William Van Antwerp
  • Patent number: 9442065
    Abstract: A synthesizer synthesizes Zyotons, waveforms that without a collision can travel substantially unperturbed in a propagation medium over a specified distance, for extracting via collision computing properties of interest of signals, such as the occurrence/absence of events and presence or concentrations of substances such as blood glucose, toxic chemicals, etc., obtained from high noise/clutter environments. The Zyotons are synthesized using base waveform families/generator functions unrelated to the signal environment. The Zyotons and corresponding carrier kernels include component(s) adapted to correspond to a signal property of interest and other component(s) adapted to correspond to other properties, such as noise and clutter. The number of each type of component(s) may be determined using a representative signal obtained from the environment that is optionally transformed via derivitization, addition of noise and/or another representative signal, etc.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: September 13, 2016
    Assignee: Zyomed Corp.
    Inventors: Sandeep Gulati, Timothy L. Ruchti
  • Publication number: 20160249836
    Abstract: A noninvasive analyzer apparatus and method of use thereof is described for spatially separating light for use in noninvasively determining an analyte concentration of a subject through use of detectors linked to multiple controlled sample illumination zone to sample detection zone distances. The controlled radial separation of illumination and detection zones yields reduced deviation in total observed optical pathlength and/or control of pathlengths in a desired tissue volume for each element of a set of detector elements. Performance using the discrete detection zones is enhanced using a combination of segmented spacers, arcs of detector elements, use of micro-optics, use of optical filters associated with individual detector elements, control of detector response shapes, and/or outlier analysis achievable through use of multiple separate and related observed signals of a detector array.
    Type: Application
    Filed: December 10, 2015
    Publication date: September 1, 2016
    Inventors: Sandeep Gulati, Timothy Ruchti, Kevin H. Hazen
  • Publication number: 20160242682
    Abstract: A noninvasive analyzer apparatus and method of use thereof is described for spatially separating light having noninvasively probed a tissue volume into groups, which narrows standard deviations of probed tissue pathlength for each of the groups. Reduction in tissue pathlength uncertainty subsequently enhances noninvasive analyte concentration determination accuracy. Control of individual detector distance from an illumination zone in combination with control of area of a detection zone coupled to an individual detector yields intensity control of the various groups.
    Type: Application
    Filed: December 10, 2015
    Publication date: August 25, 2016
    Inventors: Sandeep Gulati, Timothy Ruchti, Kevin H. Hazen
  • Publication number: 20160231236
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, illumination is directed to the medium and corresponding radiation from the medium is collected. Spectral energy changes associated with fragment(s)/feature(s) obtained from the collected radiation are determined using collision computing. Such spectral energy changes generally represent analyte concentration. The collection of radiation and/or illumination is controlled either to target a particular volume of the medium or such that the spectral energy changes become directionally monotonic with respect to analyte concentration, or both. The collection parameters include: duration of collection, location and/or a size of a collection spot on the medium surface, and angle of a collector relative to the medium surface. The illuminated and/or collection spots may be treated to improve accuracy of analyte measurement.
    Type: Application
    Filed: March 25, 2016
    Publication date: August 11, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, John L. Smith, William Van Antwerp
  • Publication number: 20160231235
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, illumination is directed to the medium and corresponding radiation from the medium is collected. Spectral energy changes associated with fragment(s)/feature(s) obtained from the collected radiation are determined using collision computing. Such spectral energy changes generally represent analyte concentration. The illumination is controlled to target a particular volume of the medium and/or such that the spectral energy changes become directionally monotonic with respect to analyte concentration.
    Type: Application
    Filed: March 25, 2016
    Publication date: August 11, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160139045
    Abstract: In a noninvasive system for detection/measurement of glucose and other analytes in a medium such as tissue, spectra from the medium are deconstructed into features. Conditioned features, which contain frequency components specific to glucose or the other analytes, are derived from one or more features by modulating a carrier kernel with the feature. The conditioned features are computationally collided with one or more Zyotons that are co-dependent with the conditioned features. One or more collisions amplify a property of the analyte e.g., energy absorbed by glucose in tissue from radiation directed to the skin. A gradient of several values of the amplified property, each value corresponding to a particular radiation pattern according to a spectroscopic tomographic sequence, is used to select a suitable projector curve, with which a representative amplified value is projected to an accurate estimate of the concentration of glucose or the other analytes, without needing personalized calibration.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160139043
    Abstract: A synthetic projection system determines analyte concentration, such as blood glucose concentration, from a spectral-energy change associated with an uncharacterized instance of a medium in which the analyte is likely present. The projection system is factory calibrated for different instances of the medium, without needing instance-specific training or calibration. The projection system includes a set of projector curves, each relating spectral-energy change values obtained by analyzing reference medium samples to analyte concentrations in those samples. Each projector curve also corresponds to a respective range of energy-change gradients, determined using a group of surrogate media characterized according to analyte concentrations measured using a reference system. A spectral-energy-change gradient for the uncharacterized medium may be computed to select one of the projectors curves.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160139041
    Abstract: A collision-computing system detects and amplifies the energy associated with a feature signal to determine occurrences or absence of events, such as ultrasonic and/or geophysical events, or to determine presence and/or concentrations of substances such as blood glucose, toxic chemicals, etc., in a noisy, high-clutter environment or sample. To this end, a conditioned feature, obtained by modulating a carrier kernel with a feature signal, is collided with a Zyoton—a waveform that without a collision can travel substantially unperturbed in a propagation medium over a specified distance. The conditioned feature and the Zyoton are particularly constructed to be co-dependent in terms of their respective dispersion velocities and the divergence of a waveform resulting from the collision. The collision operation can transfer at least a portion of the feature energy to the resulting waveform, and the transferred energy can be amplified in successive collisions for detecting/measuring events/substances.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti, William Van Antwerp, John L. Smith
  • Publication number: 20160139042
    Abstract: A synthesizer synthesizes Zyotons, waveforms that without a collision can travel substantially unperturbed in a propagation medium over a specified distance, for extracting via collision computing properties of interest of signals, such as the occurrence/absence of events and presence or concentrations of substances such as blood glucose, toxic chemicals, etc., obtained from high noise/clutter environments. The Zyotons are synthesized using base waveform families/generator functions unrelated to the signal environment. The Zyotons and corresponding carrier kernels include component(s) adapted to correspond to a signal property of interest and other component(s) adapted to correspond to other properties, such as noise and clutter. The number of each type of component(s) may be determined using a representative signal obtained from the environment that is optionally transformed via derivitization, addition of noise and/or another representative signal, etc.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 19, 2016
    Inventors: Sandeep Gulati, Timothy L. Ruchti